Revelation Biosciences Inc (REVB)
$1.59
Performance
- $1.58$1.64$1.59
0.63%
Downside
Day's Volatility :3.88%
Upside
3.27%
- $1.52$28.20$1.59
4.4%
Downside
52 Weeks Volatility :94.61%
Upside
94.36%
Returns
| Period | Revelation Biosciences Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -25.69% | 0.0% |
6 Months | -83.58% | 0.0% |
1 Year | -93.31% | 0.0% |
3 Years | -99.98% | -20.2% |
Highlights
Market Capitalization | 2.6M |
Book Value | $5.8 |
Earnings Per Share (EPS) | -48.51 |
Wall Street Target Price | 18.7 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -34.05% |
Return On Equity TTM | -91.95% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 90.9M |
EBITDA | -8.9M |
Diluted Eps TTM | -48.51 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -7.53 |
EPS Estimate Next Year | -5.23 |
EPS Estimate Current Quarter | -5.38 |
EPS Estimate Next Quarter | -5.18 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 1076.1%
Technicals Summary
Sell
Neutral
Buy
Revelation Biosciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Revelation Biosciences Inc | -18.59% | -83.58% | -93.31% | -99.98% | -99.98% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Revelation Biosciences Inc | 0.5 | NA | NA | -7.53 | -0.92 | -0.34 | NA | 5.8 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Revelation Biosciences Inc | Buy | $2.6M | -99.98% | 0.5 | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Revelation Biosciences Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 154.9%
Institutional Holdings
UBS Group AG
0.26%Tower Research Capital LLC
0.19%Advisor Group Holdings, Inc.
0.02%
Company Information
we develop immunologic therapeutics and diagnostics designed to make the world a healthier place
Organization | Revelation Biosciences Inc |
Employees | 9 |
CEO | Mr. James M. Rolke |
Industry | Regional Banks |
Discover More
A Spac I Acquisition Corp
$1.59
-1.85%
Keyarch Acquisition Corp
$1.59
-1.85%
Connexa Sports Technologies Inc
$1.59
-1.85%
Us Value Etf
$1.59
-1.85%
First Wave Biopharma Inc
$1.59
-1.85%
Global X Msci Next Emerging
$1.59
-1.85%
Fat Projects Acquisition Corp
$1.59
-1.85%
Capital Link Global Fintech
$1.59
-1.85%
Applied Uv Inc
$1.59
-1.85%